Because tirzepatide produces rapid weight loss (often 12 pounds per week in the first months), telogen effluvium becomes more likely during early treatment
While it is synthetically modified for increased stability and half-life, liraglutide shares 97% homology with the GLP-1 hormone [1]
Sin embargo, al igual que Mounjaro, Zepbound es un agonista dual porque estimula tanto el GLP-1 como el GIP
Foundayo (Orforglipron) As the newest addition, Foundayo is a daily pill with no food or water restrictions, approved in April 2026
Trulicity Dosing Schedule: Most patients begin at 0.75 mg weekly, with the standard maintenance dose typically set at 1.5 mg
Common side effects include nausea, constipation, and dehydrationmanageable with dose titration and dietary adjustments